Science & Co review

Science & Co advertises compounded semaglutide and tirzepatide, plus NAD+ and sermorelin. Its FAQ says there is no separate monthly membership, while product pages include supplies, shipping and ongoing monitoring. Those are useful disclosures, but a headline monthly equivalent is different from the amount that leaves your account. Request the selected plan total and the next processing date together before agreeing to a subscription. The GLP-1 pages lead with a twelve-month offer. Each also shows a crossed-out figure without establishing that figure as the current standalone monthly invoice. The NAD+ and sermorelin pages likewise advertise annual-plan starting rates. Earlier plan selections are not a substitute for a current confirmation: establish the upfront payment, covered term, renewal price and whether continuation is automatic. A current written quote is needed to compare the complete recurring cost.

The terms say subscriptions charge at the recurring interval disclosed during checkout. They do not establish a universal thirty-day interval for every product. Free monthly shipping describes fulfillment, not necessarily the timing of a charge or the amount of medication supplied. A longer prepaid purchase also needs its own refund and continuation terms; do not assume that the FAQ’s pause option creates a right to a prorated refund of an already purchased term. Cancellation has a practical deadline. The FAQ and shipping policy say to use the account or support email at least seventy-two hours before the next processing date. That date appears in the account and may differ from delivery. Cancellation stops future orders. The shipping policy describes final sales after a charge and carrier handoff, then excludes already dispensed orders. Product FAQs also exclude already prescribed orders. Ask which earlier stage applies to your selected purchase rather than treating shipment as a guaranteed refund window.

Science and Co operates the administrative technology platform. Its terms distinguish that company from separately operated clinical entities and dispensing pharmacies. The FAQ describes a questionnaire, state-licensed prescriber review and ongoing messaging, with the same provider staying involved. These are company descriptions, not an separately operated credential check or a guarantee about your assigned professional. Ask who reviews your history, whether a live visit or laboratory testing is needed and how urgent concerns are escalated. The product pages say US compounding pharmacies prepare the medicine and that testing documentation can be requested. That is not separately operated confirmation of a particular pharmacy’s license, inspection history or the contents of your prescription. Obtain the dispensing pharmacy’s legal name and contact details, check its authorization for your state and follow its preparation-specific label. An ingredient certificate does not by itself establish final-product sterility or clinical equivalence to an approved medicine.

For shipment problems, the published policy describes replacement and carrier tracing. It does not promise an unconditional cash refund for every lost or damaged package. Orders leave after clinical consultation and prescription issuance, so free delivery should not be read as immediate dispatch after payment. Keep tracking and packaging details, and contact the pharmacy about temperature-sensitive medicine rather than relying on an intact cold pack as proof of stability. Branded GLP-1 pathways require a separate understanding of the service fee and the medication purchased through the manufacturer’s pharmacy. Ask for both current amounts and the exact formulation; a compounded-plan quote does not cover branded treatment. The longevity catalog also illustrates glutathione with a coming-soon action despite an in-stock label. Do not treat that mixed display, or a hormone navigation link, as proof that the product is presently orderable.

The FAQ advertises service in all fifty states and DC. That is a company availability statement, not proof that every preparation is available to every resident. The clinical team must confirm the specific prescription and applicable state requirements. The service is cash-pay and says it does not submit insurance claims. HSA/FSA eligibility depends on the expense and administrator; accepting a payment card does not guarantee tax treatment or reimbursement. Finally, outcome illustrations and testimonials are not evidence that a particular compounded preparation produces the same results as a branded trial drug. NAD+ and sermorelin listings do not establish improvements in energy, recovery or sleep. A patient-specific prescription alone does not satisfy every compounding condition. Discuss the clinical rationale and approved alternatives with the prescriber, separately operatedly of the subscription’s commercial appeal.